iifl-logo

Strides Pharma Science Ltd Key Ratios

909.75
(-0.14%)
Sep 12, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

FINANCIALS

Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

20.49

-3.07

3.04

-3.72

Op profit growth

23.05

30.09

-24.8

27.38

EBIT growth

21.41

17.45

-40.14

50.01

Net profit growth

637.66

-94.49

65.22

268.35

Profitability ratios (%)

OPM

19.14

18.74

13.96

19.13

EBIT margin

14.47

14.36

11.85

20.4

Net profit margin

8.09

1.32

23.26

14.5

RoCE

9.54

7.42

5.4

8.66

RoNW

2.53

0.36

6.33

3.69

RoA

1.33

0.17

2.65

1.54

Per share ratios (₹)

EPS

28.74

3.42

76.47

49.87

Dividend per share

2.5

14

2

4.5

Cash EPS

6.93

-15.33

56.58

30.59

Book value per share

309.61

282.18

275.26

307.39

Valuation ratios

P/E

12.87

41.32

3.72

9.32

P/CEPS

53.39

-9.21

5.03

15.2

P/B

1.19

0.5

1.03

1.51

EV/EBIDTA

14.19

8.58

16.77

19.14

Payout (%)

Dividend payout

0

0

2.71

10.06

Tax payout

-9.59

-4.72

-6.93

-16.72

Liquidity ratios

Debtor days

112.19

120.28

120.71

134.37

Inventory days

109.15

88.5

82.58

89.14

Creditor days

-137.83

-125.48

-111.53

-128.11

Leverage ratios

Interest coverage

-3.19

-2.53

-1.71

-3.07

Net debt / equity

0.78

0.79

0.89

1.22

Net debt / op. profit

3.41

3.87

5.58

6.39

Cost breakup (₹)

Material costs

-40.19

-40.78

-48.56

-46.49

Employee costs

-16.59

-16.08

-15.28

-15.21

Other costs

-24.06

-24.38

-22.18

-19.15

Strides Pharma : related Articles

Strides Pharma inks partnership with Kenox to develop nasal spray products for US market

Kenox, a contract drug maker with a focus on inhaled and nasal products, will handle formulation and development, while Strides brings in manufacturing scale and market access.

9 Sep 2025|10:04 AM
Read More
Top Stocks for Today - 9th September 2025

Here are some of the stocks that may see significant price movement today: Infosys, Brigade Enterprises, Strides Pharma, etc.

9 Sep 2025|07:57 AM
Read More
Strides Pharma Q3 Profit at ₹90 Crore, Revenue Up 15%

EBITDA grew 48% YoY at ₹210 crore, from ₹142 crore in the same quarter last year, marking better profitability.

31 Jan 2025|11:55 AM
Read More
Strides Pharma Posts ₹93 Crore Q2 Profit

EBITDA rose significantly to ₹235.7 Crore, a 54% increase from ₹153 Crore in the corresponding period of the previous year.

28 Oct 2024|05:13 PM
Read More
Strides Pharma gets shareholders’ approval for CDMO unit

In September 2023, the pharmaceutical behemoth revealed OneSource. The stock exchanges approved the idea earlier this year, in May.

11 Sep 2024|03:17 PM
Read More
Strides gets US FDA nod for Theophylline tablets

The medication is bioequivalent and therapeutically equivalent to Schering Corp's Reference Listed Drug (RLD), THEO-DUR.

6 Sep 2024|12:18 PM
Read More
Strides Pharma's Chennai Facility Receives USFDA Approval

The Alathur facility is key to Strides' global operations, especially in the US and other regulated markets, specializing in the production of tablets and capsules.

19 Aug 2024|03:21 PM
Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.